Arpida purchased TLT Medical Ltd.

Arpida, a biopharmaceutical company listed on the SWX Swiss Exchange, purchased all shares in Swiss biotechnology group TLT Medical Ltd. for an undisclosed consideration.

Lenz & Staehelin advised Arpida. Lenz & Staehelin's team was led by Lukas Morscher and included Philipp Jermann.

Published: 30 August 2007
Lenz & Staehelin {PAGENO}/{nbpg}
{PAGENO}/{nbpg}